Introduction: The role of atypical antipsychotics in the treatment of bipolar disorder

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 3, 2005, Pages 3-4

  Hirschfeld, Robert M A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; HYPERPROLACTINEMIA; MAINTENANCE THERAPY; METABOLIC DISORDER; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 16244395136     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (2)

1. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-151
2. Murray CJL, Lopez AD, eds. Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, vol 1. Cambridge, Mass: Harvard University Press; 1996